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Abstract
Background: The objective of this study was to review the available prospective, randomized, con-
trolled trials to determine whether an early (ELC) or a delayed (DLC) approach to a laparoscopic chole-
cystectomy is associated with an increase in length of hospitalization after acute cholecystitis.
Methods: Medline, the Cochrane Trials Register and EMBASE were searched for prospective, ran-
domized, controlled trials (RCTs) comparing ELC versus DLC, published up to May 2014. A meta-
analysis was performed using Review Manager 5.0.
Results: Nine RCTs were included in a total of 617 who underwent ELC and 603 patients who under-
went DLC after acute cholecystitis. The mean hospital stay was 5.4 days in the ELC group and
9.1 days in the DLC group. The meta-analysis showed a mean hospital stay significantly lower in the
ELC group [medical doctor (MD) = 3.24, 95% confidence interval (CI) = 1.95–4.54, P < 0.001]. The
major biliary duct injury rate in the ELC group was 0.8% (2/247) and 0.9% (2/223) in the DLC group.
The meta-analysis showed no significant difference between the ELC and DLC groups [relative risk
(RR) =0.96, 95%CI = 0.25–3.73, P = 0.950].
Conclusion: DLC is associated with a longer total hospital stay but equivalent morbidity as compared
to ELC for patients presenting with acute cholecystitis. ELC would appear to be the treatment of
choice for patients presenting with ELC.
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Introduction
Acute cholecystitis is due to gallstones in up to 90% of patients.
The reported prevalence of gallstones is up to 10% in adult
Eastern populations and up to 15% in adult Western popula-
tions.1 It is estimated that 20–40% of individuals with gallstones
will develop associated symptoms, and 12% will develop acute
cholecystitis.2–4 A laparoscopic cholecystectomy is currently the
gold standard treatment for symptomatic gallstone disease.
However, the optimal timing of a cholecystectomy in patients
with acute cholecystitis remains controversial. A laparoscopic
cholecystectomy is usually delayed in these patients because of
fears that early surgery may be associated with a higher rate of
morbidity including post-operative bile leakage, and a higher
rate of conversion to open surgery5. The updated Tokyo Guide-
lines suggest that an early laparoscopic cholecystectomy (ELC)
is mandatory for patients with mild cholecystitis, whereas
delayed laparoscopic cholecystectomy (DLC) can be performed
in patients with moderate or severe cholecystitis.5
This aim of this meta-analysis was to review data from
prospective randomized controlled trials (RCTs) that com-
pared outcomes after ELC and DLC in patients with acute
cholecystitis, to investigate the length of total hospital stay
between these two approaches.
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Methods
Data sources
A systematic review of the literature was performed. Articles
published up to May 2014 by searching abstracts in Medline,
the Cochrane database and Cochrane Clinical Trials Registry,
and EMBASE, using the search terms [acute cholecystitis]
AND [early] AND [delayed] AND [laparoscopic cholecystec-
tomy] AND [random*] were identified. The search was lim-
ited to articles published in English. Two researchers
independently searched for articles and compared their
results. No unpublished data, data published in an abstract
form only or non-full-length articles were included in the
analysis.
Inclusion and exclusion criteria
Only prospective RCTs were included in this study. Laparo-
scopic cholecystectomy procedures performed for any reason
were included. The search was limited to RCTs that com-
pared outcomes after ELC and DLC in humans. The rates
of post-operative bile leakage, major bile duct injury, conver-
sion to open surgery, and overall morbidity, the presence or
absence of postoperative drainage, the operative time and
the total length of hospital stay were recorded. Observational
studies, case reports and prospective studies were excluded.
Outcome definitions
The total length of hospital stay was defined as the total num-
ber of days in the hospital, which included two hospitalizations
for patients who underwent DLC. Bile leakage was defined as
bile detected in the drainage fluid or an intra-abdominal col-
lection. A major bile duct injury was defined according to the
Bismuth and Blumgart classification6. The intra-abdominal
fluid collection was defined as detection of intra-abdominal
fluid on post-operative ultrasonography or computed tomogra-
phy.
Data review and extraction
Two researchers (B.M., J.L.) independently searched the data-
bases; reviewed titles, abstracts and full-length articles; and
selected articles to include in the analysis. The researchers also
reviewed the reference lists of selected articles and previously
published meta-analyses on the subject. Differences of opinion
were resolved by consensus that included a third researcher
(A.M.). The following information was extracted from the
included studies: the date and design of the study; the number
of patients who underwent ELC and DLC; the gender and age
of patients and the number lost to follow-up; and the inclusion
and exclusion criteria, outcome definitions, presence or
absence of routine cholangiography, experience of the surgeons
(consultant or trainee) and numbers of patients who received
failed conservative treatment for acute cholecystitis. Missing
data were requested from the authors of the relevant studies.
The quality of the studies was determined using the Jadad
scale.7
Statistical analyses
All statistical analyses were performed using Review Manager
5.0 software (Cochrane Collaboration, Oxford, UK). A fixed
model was used if there was no evidence of heterogeneity, and
otherwise a random effects model was used. Heterogeneity was
assessed using the I2 statistic, with values > 50% considered to
indicate significant heterogeneity. Odds ratios (ORs) were cal-
culated for each trial from the number of evaluable patients,
and 95% confidence intervals (CIs) were calculated to confirm
the effect size estimation and test criteria. The Mantel–Haenszel
OR was calculated for dichotomous variables and the relative
risk (RR) was calculated for rare events. The P-value for
the overall effect was calculated using the Z test, with signifi-
cance set at P < 0.05. Sensitivity analysis and estimation of
publication bias were also performed.
Results
Trial characteristics
The process for selection of studies is shown in Figure 1. These
nine studies that met inclusion criteria included 617 patients
who underwent ELC and 603 who underwent DLC after acute
cholecystitis8–16. The characteristics of these studies are shown
in Table 1.
Results of meta-analysis
Total length of hospital stay
The total length of hospital stay was reported in all nine stud-
ies. The mean total length of hospital stay was significantly
lower in patients who underwent ELC than in patients who
underwent DLC (5.4 days versus 9.1 days; medical doctor
(MD), 3.24; 95% CI, 1.95–4.54; P < 0.001) (Fig. 2).
Bile leakage
Post-operative bile leakage was reported in eight of the nine
studies (1170 patients). The rate of bile leakage was signifi-
cantly higher after ELC than after DLC (14/592, 2.4% versus
3/578, 0.3%; RR, 2.55; 95% CI, 1.05–6.20; P = 0.041) (Fig. 3).
Major bile duct injury
Major bile duct injury was reported in six of the nine studies
(480 patients). The rate of major bile duct injury was not sig-
nificantly different after ELC than after DLC (2/247, 0.8% ver-
sus 2/223, 0.9%; RR, 0.96; 95% CI, 0.25–3.73; P = 0.950).
Overall morbidity
Post-operative morbidity was reported in all nine studies.
Overall morbidity was not significantly different after ELC than
after DLC (91/617, 14.7% versus 129/603, 21.4%; OR, 1.04;
95% CI, 0.51–2.10; P = 0.91).
HPB 2015, 17, 857–862 ª 2015 International Hepato-Pancreato-Biliary Association
858 HPB
Intra-abdominal fluid collection
Post-operative intra-abdominal fluid collection was reported in
five of the nine studies (998 patients). The rate of intra-
abdominal fluid collection was not significantly different after
ELC than after DLC (7/506, 1.4% versus 8/492, 1.6%; RR,
0.79; 95% CI, 0.31–2.06; P = 0.63).
Conversion to open surgery
Conversion to open surgery was reported in all nine studies.
The rate of conversion was not significantly different after ELC
than after DLC (86/617, 13.9% versus 84/603, 13.9%; RR, 0.97;
95% CI, 0.74–1.28; P = 0.84).
Operative time
The operative time was reported in seven of the nine studies
(530 patients). The mean operative time was not significantly
different between ELC and DLC (105 min versus 91 min; MD,
10.18; 95% CI, 1.48–21.85; P = 0.09).
Post-operative drainage
Post-operative drainage was reported in three of the nine studies
(186 patients). Placement of an intra-operative drainage tube
was significantly more frequent in patients who underwent ELC
than in patients who underwent DLC (74/95, 77.8% versus
37.3%; OR, 6.18; 95% CI, 3.19–11.99; P < 0.001) (Fig. 4).
Sensitivity analysis and publication bias
Sensitivity analysis and publication bias estimation were per-
formed to estimate statistically significant results. For overall
morbidity, operative time and the total length of hospital stay,
the combined OR (or MD) was calculated using both a fixed-
effects and a random-effects model, and the results were com-
pared.
Discussion
This meta-analysis of RCTs found that DLC was associated
with a significantly longer total hospital stay and significantly
lower rate of post-operative bile leakage than ELC in patients
with acute cholecystitis. However, the rates of major bile duct
injury, overall morbidity and conversion to open surgery, and
the mean operative time, were not significantly different
between ELC and DLC.
The choice of ELC versus DLC in patients with acute chole-
cystitis remains controversial, even although this issue has been
investigated by randomized8 and prospective studies.17–20 All
these previous studies concluded that the rates of post-opera-
tive complications and conversion to open surgery were similar
after ELC and DLC. These results are also supported by a
recent population-based study,21 which found that ELC was
associated with a shorter total hospital stay and a similar rate
of post-operative complications compared with DLC.
Other previous studies have also reported on the total length
of hospital stay.31,32 The length of hospital stay and cost-effec-
tiveness have become increasingly important in recent years.
Some centres prefer to avoid DLC because it requires a second
hospitalization, which increases the total length of hospital stay
and is associated with a risk of recurrence of cholecystitis
before surgery. As reported, there were some patients who
underwent their surgery before the operative date in the DLC
group (Table 1).
This meta-analysis has some limitations. First, the timing of
ELC and DLC differed among studies. ELC was performed as
soon as 24 h after admission in some studies,8,11,15,16 at
48–72 h after admission in other studies,9,10,12,14 and as late as
7 days after admission in the study by Yadav et al.13 DLC was
performed between 6 and 12 weeks after acute cholecystitis.
Analysis of the secondary outcomes of the study found that
post-operative bile leakage was significantly associated with
ELC. This differs from the findings of previous meta-analyses
and RCTs. However, interpreting the significance of this result
is difficult as the rates of post-operative drainage were signifi-
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Figure 1 Flow-Chart of the meta-analysis
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cantly higher in the ELC group and, thus, may have influenced
the reported incidence. Outcome data regarding morbidity or
subsequent intervention would need to be reported to under-
stand if this is significant.
Bile duct injuries are a major concern after a cholecystec-
tomy and are divided into minor and major injuries accord-
ing to the Strasberg classification.22 After a laparoscopic
cholecystectomy, the reported rate of minor bile duct injuries
is 0.1–1.7%, and of major bile duct injuries is 0.1–0.9%.
Obesity, peri-operative bleeding and local inflammation sec-
ondary to pancreatitis or acute cholecystitis are well-known
risk factors for bile duct injury.23,24 In patients with bile duct
injuries, the right hepatic artery is also injured in 7–12% of
patients.25–30
Table 1 Characteristics of studies included in the meta-analysis
Study (year,
Country)
Number of
patients
(ELC/DLC)
Outcomes definition (according to TG 13
for AC)
Monocentre
study
Consultant
surgeon
Routinely
cholangiography
Failure of
conservative
treatment
AC ELC DLC
Lai (1998, China) 53/38 Yes Within 24 h
of admission
6–8 weeks
later
Yes Yes No 8
Lo (1998, China) 45/41 Yes Within 72 h
of admission
8–12 weeks
later
Yes Yes No 8
Johansson (2003,
Sweden)
74/69 Yes Within 48 h
of admission
but no more
than 7 days
after the onset
of the symptoms
6–8 weeks
later
Yes No Yes 18
Kolla (2004, India) 20/20 Yes Within 24 h
of admission
6–12 weeks
later
Yes Yes No
Macafee (2009,
United
Kingdom)
36/36 Not
detailed
in the
study
Within 72 h
of admission
12 weeks
later
Yes No Considered only
necessary
by surgeon
4
Yadav (2009,
Nepal)
No As soon as possible
but until 7 days
within admission
6–8 weeks
later
Yes Yes NR NR
Gul (2013, India) 30/30 Yes Within 72 h
of admission
6–12 weeks
later
Yes Yes Not detailed in
the study
Not detailed
in the study
Gutt (2013,
Germany)
304/314 Yes Within 24 h
of admission
Until 45 days
after
enrollment
No Not detailed
in the study
Not detailed in
the study
Not detailed
in the study
Ozkardes
(2014,
Turkey)
30/30 Yes Within 24 h
of admission
6–8 weeks later Yes No Not detailed in
the study
Not detailed
in the study
AC, acute cholecystitis; DLC, delayed laparoscopic cholecystectomy; ELC, early laparoscopic cholecystectomy; US, ultrasound; TG 13, Tokyo
Guidelines 2013 definition.
ELC
Lo 1998
Lai 1998
Johansson 2003
Kolla 2004
Macafee 2009
Yadav 2009
Gutt 2013
Gul 2013
Ozkardes 2014
Heterogeneity: Tau2 = 2.59; Chi2 = 93.06, d.f. = 7 (P  < 0.00001); l2 = 92%
Test for overall effect: Z = 4.92 (P < 0.00001)
Total (95% CI)
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Figure 2 Meta-analysis of the total length hospital stay
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The present findings that the rates of overall morbidity,
major bile duct injury and mortality were not significantly dif-
ferent between patients who underwent ELC and DLC were
consistent with the findings of four previous meta-analyses.
However, Siddiqui et al.31 found that ELC was associated with
a longer mean operative time than DLC, which differs from
the present findings.
The findings of recent studies suggest that ELC may reduce
healthcare costs33–35 and increase the quality of life36,37 com-
pared with DLC in patients with acute cholecystitis.
Conclusion
DLC is associated with a longer total hospital stay but equiva-
lent morbidity as compared with ELC for patients presenting
with acute cholecystitis. ELC would appear to be the treatment
of choice for patients presenting with AC.
Acknowledgements
None.
Funding sources
Nothing to disclose.
Conflict of interest
None declared.
References
1. Gurusamy KS, Davidson C, Gluud C, Davidson BR. (2013) Early versus
delayed laparoscopic cholecystectomy for people with acute cholecysti-
tis. Cochrane Database Syst Rev 6:CD005440.
2. Stinton LM, Myers RP, Shaffer EA. (2010) Epidemiology of gallstones.
Gastroenterol Clin North Am 39:157–159.
3. Portincasa P, Moschetta A, Palasciano G. (2006) Cholesterol gallstone
disease. Lancet 368:230–239.
4. Portincasa P, Moschetta A, Petruzzelli M, Palasciano G, Di Ciaula A,
Pezzolla A. (2006) Gallstone disease: symptoms and diagnosis of gall-
bladder stones. Best Pract Res Clin Gastroenterol 20:1017–1029.
5. Gomi H, Solomkin JS, Takada T, Strasberg SM, Pitt HA, Yoshida M
et al. (2013) TG13 antimicrobial therapy for acute cholangitis and chole-
cystitis. J Hepatobiliary Pancreat Sci 20:60–70.
6. Bismuth H, Majno PE. (2001) Biliary strictures: classification based on
the principles of surgical treatment. World J Surg 25:1241–1244.
ELC DLC Odds Ratio Odds Ratio
M-H, Fixed, 95% CIYearM-H, Fixed, 95% CIStudy or Subgroup Total TotalEventsEvents Weight
95 91 100.0% 6.18 [3.19, 11.99] 
Total events
Total (95% CI)
Heterogeneity: Chi2 = 0.97, d.f. = 2 (P = 0.62); l2 = 0%
Test for overall effect: Z = 5.39 (P < 0.00001)
1 10 1000.01 0.1
ELC DLC
Lo 1998 39 45 18 41 34.8% 8.31 [2.88, 23.92] 1998
2004
2013
7.43 [1.78, 31.04]
4.03 [1.37, 11.84]
19.4%
45.8%
20
30
7
9
20
30
16
19
3474
Kolla 2004
Gul 2013
Figure 4 Meta-analysis of the post-operative drainage
Study or Subgroup Total Total
ELC DLC Odds Ratio Odds Ratio
M-H, Fixed, 95% CIM-H, Fixed, 95% CIEventsEvents Weight Year
1 53 2.20 [0.09, 55.48]
0.17 [0.01, 3.73]
3.15 [0.12, 82.16]
3.08 [0.12, 78.27]
3.10 [0.12, 79.23]
3.12 [0.32, 30.16]
3.10 [0.12, 79.23]
2.60 [1.05, 6.43]100.0%578592
13.19 [0.73, 238.69]7.3%
7.2%
7.4%
7.3%
7.3%
15.0%
39.8%41
38 8.7% 1998
1998
2003
2004
2009
2013
2013
2014
1 10 1000.01 0.1
ELC DLC
69
20
36
30
30
314
45
74
20
36
30
30
304
0
0
0
0
0
0
1
0
2
6
1
1
1
3
1
Lai 1998
Lo 1998
Johansson 2003
Kolla 2004
Macafee 2009
Gutt 2013
Gul 2013
Ozkardes 2014
Total (95% CI)
Total events 14 3
Heterogeneity: Chi2 = 4.28, d.f. = 7 (P = 0.75); l2 = 0%
Test for overall effect: Z = 2.06 (P = 0.04)
Figure 3 Meta-analysis of the post operative bile leakage
HPB 2015, 17, 857–862 ª 2015 International Hepato-Pancreato-Biliary Association
HPB 861
7. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan
DJ et al. (1996) Assessing the quality of reports of randomized clinical
trials: is blinding necessary? Control Clin Trials 17:1–12.
8. Lai P, Kwong K, Leung K, Kwok SP, Chan AC, Chung SC et al. (1998)
Randomized trial of early versus delayed laparoscopic cholecystectomy
for acute cholecystitis. Br J Surg 85:764–767.
9. Lo CM, Liu CL, Fan ST, Lai EC, Wong J. (1998) Prospective randomized
study of early versus delayed laparoscopic cholecystectomy for acute
cholecystitis. Ann Surg 227:461–467.
10. Johansson M, Thune A, Blomqvist A, Nelvin L, Lundell L. (2003) Man-
agement of acute cholecystitis in the laparoscopic era: results of a pro-
spective randomized clinical trial. J Gastrointest Surg 7:642–645.
11. Kolla SB, Aggarwal S, Kumar A, Kumar R, Chumber S, Parshad R et al.
(2004) Early versus delayed laparoscopic cholecystectomy for acute
cholecystitis. Surg Endosc 18:1323–1327.
12. Macafee DA, Humes DJ, Bouliotis G. (2009) Prospective randomized
trial using cost-utility analysis of early versus delayed laparoscopic cho-
lecystectomy for acute gallbladder disease. Br J Surg 96:1031–1040.
13. Yadav RP, Adhikary S, Agrawal CS, Bhattarai B, Gupta RK, Ghimire A.
(2009) A comparative study of early versus delayed laparoscopic chole-
cystectomy in acute cholecystitis. Kathmandu Univ Med J (KUMJ) 7:16–
20.
14. Gul R, Dar R, Sheikh R, Salroo NA, Matoo AR, Wani SH. (2013) Com-
parison of early versus delayed laparoscopic cholecystectomy for acute
cholecystitis: experience from a single center. N Am J Med Sci 5:414–
418.
15. Gutt C, Encke J, K€oninger J, Harnoss JC, Weigand K, Kipfm€uller K
et al. (2013) Early versus delayed cholecystectomy, a multicenter ran-
domized trial (ACDC study, NCT00447304). Ann Surg 258:385–393.
16. Ozkardes AB, Tokac M, Dumlu EG, Bozkurt B, Ciftci AB, Yetisir F et al.
(2014) Early versus delayed laparoscopic cholecystectomy for acute
cholecystitis: a prospective randomized study. Int Surg 99:56–61.
17. Pessaux P, Tuech JJ, Rouge C, Duplessis R, Cervi C, Arnaud JP.
(2000) Laparoscopic cholecystectomy in acute cholecystitis. Surg En-
dosc 14:358–361.
18. Serralta A, Bueno J, Planells M,Rodero DR. (2003) Prospective evalua-
tion of emergency versus delayed laparoscopic cholecystectomy for
early cholecystitis. Surg Laparosc Endosc Percutan Tech 13:71–75.
19. Gonzalez-Rodriguez F, Paredes-Cotore J, Ponton C, Rojo Y, Flores E,
Luis-Calo ES et al. (2009) Early versus laparoscopic cholecystectomy in
acute cholecystitis? Conclusion of a controlled trial Hepatogastroente-
rology 56:11–16.
20. Teckchandani N, Garg P, Hadke N, Jain SK, Kant R, Mandal AK et al.
(2010) Predictive factors for successful early laparoscopic cholecystec-
tomy in acute cholecystitis: a prospective study. Int J Surg 8:623–627.
21. De Mestral C, Rotsein O, Laupacis A, Hoch JS, Zagorski B, Alali AS
et al. (2014) Comparative operative outcomes of early and delayed cho-
lecystectomy for acute cholecystitis. A population-based propensity
score analysis. Ann Surg 259:10–15.
22. Strasberg SM, Hertl M, Soper NJ. (1995) An analysis of the problem of
biliary duct injury during laparoscopic cholecystectomy. J Am Coll Surg
180:101–125.
23. Schmidt SC, Langrehr JM, Hintze RE, Neuhaus P. (2005) Long-term
results and risk factors influencing outcome of major bile duct injuries
following cholecystectomy. Br J Surg 92:76–82.
24. S€oderlund C, Frozanpor F, Linder S. (2005) Bile duct injuries at
laparoscopic cholecystectomy: a single-institution prospective study.
Acute cholecystitis indicates an increased risk. World J Surg 29:987–
993.
25. Halasz NA. (1991) Cholecystectomy and hepatic artery injuries. Arch
Surg 126:137–138.
26. Alves A, Farges O, Nicolet J, Watrin T, Sauvanet A, Belghiti J. (2003)
Incidence and consequence of an hepatic artery injury in patients with
postcholecystectomy bile duct strictures. Ann Surg 238:93–96.
27. Buell JF, Cronin DC, Funaki B, Koffron A, Yoshida A, Lo A et al (2002)
Devastating and fatal complications associated with combined vascular
and bile duct injuries during cholecystectomy. Arch Surg 137:703–708.
28. Mathisen O, Søreide O, Bergan A. (2002) Laparoscopic cholecystec-
tomy: bile duct and vascular injuries: management and outcome. Scand
J Gastroenterol 37:476–481.
29. Boerma D, Rauws EA, Keulemans YC, Janssen IM, Bolwerk CJ, Timmer
R et al. (2001) Impaired quality of life 5 years after bile duct injury dur-
ing laparoscopic cholecystectomy: a prospective analysis. Ann Surg
234:750–757.
30. Stewart L, Way LW. (2009) Laparoscopic bile duct injuries: timing of
surgical repair does not influence success rate. A multivariate analysis
of factors influencing surgical outcomes. HPB 11:516–522.
31. Siddiqui T, MacDonald A, Chong P, Jenkins JT. (2008) Early versus
delayed laparoscopic cholecystectomy for acute cholecystitis: a meta-
analysis of randomized controlled trials. Am J Surg 195:40–47.
32. Lau H, Lo C, Patil G, Yuen WK. (2006) Early versus delayed-interval lap-
aroscopic cholecystectomy for acute cholecystitis. A meta-analysis.
Surg Endosc 20:82–87.
33. Wilson E, Gurusamy K, Gluud C, Davidson BR. (2010) Cost-utility and
value-of-information analysis of early versus delayed laparoscopic cho-
lecystectomy for acute cholecystitis. Br J Surg 97:210–219.
34. Dixon E, Fowler D, Ghitulescu G, Evidence Based Reviews in Surgery
Group. (2012) Cost-utility analysis of early versus delayed laparoscopic
cholecystectomy for acute cholecystitis. J Can Chir 55:204–206.
35. Johner A, Raymakers A, Wiseman S. (2013) Cost-utility of early versus
delayed laparoscopic cholecystectomy. Surg Endosc 27:256–262.
36. Johansson M, Thune A, Blomqvist A, Nelvin L, Lundell L. (2004) Impact
of choice of therapeutic strategy for acute cholecystitis on patient’s
health-related quality of life. Results of a randomized, controlled clinical
trial. Dig Surg 21:359–362.
37. Morris S, Gurusamy K, Patel N, Davidson BR. (2014) Cost-effectiveness
of early laparoscopic cholecystectomy for mild acute gallstone pancrea-
titis. Br J Surg 101:828–835.
HPB 2015, 17, 857–862 ª 2015 International Hepato-Pancreato-Biliary Association
862 HPB
